Provider of digital 3D printing solutions for personalized medicine. The company has developed a platform that enables sustainable, quality-controlled production of personalized medicine through its pharmaceutical printing technology. It is a smart drug formulation platform that incorporates cutting-edge technology to redefine the drug compounding process. Founded in 2021, headquartered in Helsinki, Finland. The company has raised $33.8M in funding at the series a stage. CurifyLabs operates in the 3D Printing, Life Sciences Tech, Life Sciences Platforms and Tools sectors. The company focuses on Medicinal Pills, 3D Printing, 3D Bioprinting. Notable investors include EIC Fund, Europa, Springvest, Finpro, Sandwater, Healthcap, among others.
← All startups
CurifyLabs
Series AProvider of digital 3D printing solutions for personalized medicine. The company has developed a platform that enables sustainable, quality-controlled production of personalized medicine through its pharmaceutical printing technology. It is a smart drug formulation platform that incorporates cutting-edge technology to redefine the drug compounding process. Founded in 2021, headquartered in Helsinki, Finland. The…
About
Business model
3D Printing > Applications > Healthcare > Medicinal Pills,
Life Sciences Tech > Manufacturing > 3D Printing,
Life Sciences Platforms and Tools > Instruments > 3D Bioprinting
Institutional investors
EIC FundEuropaSpringvestFinproSandwaterHealthcapTesiLifeline VenturesHealth Incubator HelsinkiExcedea
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Backed by funds in our directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.